Featured Research

from universities, journals, and other organizations

Do Increased Levels Of Testosterone Play A Role In Sudden Infant Death Syndrome?

Date:
November 17, 2005
Source:
Elsevier Health Sciences
Summary:
Sudden Infant Death syndrome (SIDS) is the leading cause of unexpected death in infants ages one week to one year old. Although the number of SIDS related deaths has decreased due to greater public awareness regarding infants' sleep positions, the cause of SIDS remains unknown. However, a study in the November issue of The Journal of Pediatrics shows that elevated testosterone levels may put infants at greater risk for SIDS.

Sudden Infant Death syndrome (SIDS) is the leading cause of unexpected death in infants ages one week to one year old. Although the number of SIDS related deaths has decreased due to greater public awareness regarding infants' sleep positions, the cause of SIDS remains unknown. However, a study in the November issue of The Journal of Pediatrics shows that elevated testosterone levels may put infants at greater risk for SIDS.

Michael Emery, PhD, from the University of Washington, and colleagues tested estrogen and testosterone levels in the blood serum of 127 infants who had died of SIDS and 42 infants who had died of other causes of unexpected infant death. They found that the testosterone levels in the male SIDS infants were 120% higher than in male non-SIDS infants and 50% higher in female SIDS infants than in female non-SIDS infants. Estrogen levels were not different among the SIDS and non-SIDS infants.

"These results may be important for better understanding of SIDS because the known relationship between testosterone and breathing during sleep provides a mechanism that potentially contributes to SIDS," says Dr. Emery. Previous studies have indicated that higher levels of testosterone may result in depressed breathing during sleep, which in turn may increase the risk of SIDS.

###

The study is reported in "Serum Testosterone and Estradiol Levels in Sudden Infant Death" by Michael J. Emery, PhD, Henry F. Krous, MD, Julie M. Nadeau-Manning, MSW, Brett T. Marck, BA, and Alvin M. Matsumoto, MD. The article appears in The Journal of Pediatrics, Volume 147, Number 5 (November 2005), published by Elsevier.


Story Source:

The above story is based on materials provided by Elsevier Health Sciences. Note: Materials may be edited for content and length.


Cite This Page:

Elsevier Health Sciences. "Do Increased Levels Of Testosterone Play A Role In Sudden Infant Death Syndrome?." ScienceDaily. ScienceDaily, 17 November 2005. <www.sciencedaily.com/releases/2005/11/051117114647.htm>.
Elsevier Health Sciences. (2005, November 17). Do Increased Levels Of Testosterone Play A Role In Sudden Infant Death Syndrome?. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/11/051117114647.htm
Elsevier Health Sciences. "Do Increased Levels Of Testosterone Play A Role In Sudden Infant Death Syndrome?." ScienceDaily. www.sciencedaily.com/releases/2005/11/051117114647.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins